IRF3 antibody (Intermediate Domain)
Quick Overview for IRF3 antibody (Intermediate Domain) (ABIN500056)
Target
See all IRF3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Intermediate Domain
-
Specificity
- IRF3 antibody antibody was raised against a peptide corresponding to 14 amino acids near the center of human IRF3.
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogen
- Human IRF3 (Intermediate Domain) Peptide
-
Isotype
- IgG
-
-
-
-
Application Notes
-
ELISA. Western Blot: 1 - 2 μg/mL. Immunocytochemistry.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS containing 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C.
-
-
- IRF3 (Interferon Regulatory Factor 3 (IRF3))
-
Alternative Name
- IRF3
-
Background
- Interferons (IFN)s are involved in a multitude of immune interactions during viral infections and play a major role in both the induction and regulation of innate and adaptive antiviral mechanisms (1 for review). During infection, host-virus interactions signal downstream molecules such as transcription factors such as IFN regulatory factor-3 (IRF3) which can act to stimulate transcription of IFN-alpha/beta genes. IRF3 is present in an inactive form in the cytoplasm of most cells (2). Following viral infection, IRF3 can be activated by IkappaB kinase-epsilon and TANK-binding kinase 1 (TBK1) (3,4), whereupon IRF3 translocates to the nucleus. IRF3 can also be activated by stimulation of toll-like receptor 3 (TLR3) by dsRNA (3,5). IRF3 exists as at least two distinct isoforms.Synonyms: IRF-3, Interferon regulatory factor 3
-
Gene ID
- 3661
-
NCBI Accession
- NP_001562
-
UniProt
- Q14653
-
Pathways
- TLR Signaling, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Hepatitis C, Toll-Like Receptors Cascades
Target
-